Sysmex (OTCMKTS:SSMXY) Shares Gap Down Following Weak Earnings

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $13.55, but opened at $12.89. Sysmex shares last traded at $12.89, with a volume of 551 shares trading hands.

The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.01). The business had revenue of $895.73 million during the quarter, compared to analyst estimates of $859.71 million. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, the stock has a consensus rating of “Hold”.

Sysmex Stock Down 4.9%

The business’s 50 day moving average is $12.03 and its 200-day moving average is $10.05. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. The company has a market cap of $7.84 billion, a PE ratio of 30.69 and a beta of 1.19.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.